000 01357 a2200373 4500
005 20250516150630.0
264 0 _c20140812
008 201408s 0 0 eng d
022 _a1976-3786
024 7 _a10.1007/s12272-013-0150-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHuang, Chia-Hsin
245 0 0 _aMonacolin K affects lipid metabolism through SIRT1/AMPK pathway in HepG2 cells.
_h[electronic resource]
260 _bArchives of pharmacal research
_cDec 2013
300 _a1541-51 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAMP-Activated Protein Kinases
_xmetabolism
650 0 4 _aAnticholesteremic Agents
_xpharmacology
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHep G2 Cells
650 0 4 _aHumans
650 0 4 _aLipid Metabolism
_xdrug effects
650 0 4 _aLovastatin
_xpharmacology
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aSirtuin 1
_xmetabolism
700 1 _aShiu, Shin-Mau
700 1 _aWu, Min-Tze
700 1 _aChen, Wei-Lu
700 1 _aWang, Shyang-Guang
700 1 _aLee, Horng-Mo
773 0 _tArchives of pharmacal research
_gvol. 36
_gno. 12
_gp. 1541-51
856 4 0 _uhttps://doi.org/10.1007/s12272-013-0150-2
_zAvailable from publisher's website
999 _c22735745
_d22735745